Novo Nordisk's pricing approaches in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who's got accused the company of rate gouging, stating the stark distinction amongst U.S. price ranges and those in Europe and copyright.Comprehension the creation expenditures is important for everyone wanting to navigate the complexities